Salmon Evolution ASA: Results for Q3 2023
Highlights in the quarter:
- Strong biological performance. Standing biomass of 2,100 tonnes per 30 September, up from 1,047 tonnes per
30 June 2023 . - All-time high biomass production with 1,290 tonnes in net biomass growth.
- Quarterly run-rate net biomass growth of 1,600 – 1,700 tonnes end of September, about 70-75 % of steady-state levels.
- Parts of batch 3 harvested in September yielding 185 tonnes HOG with 96 % superior share, tight weight concentration and good price realization. Expecting significant ramp up of harvest volumes in Q4.
- On track for production cost on par with conventional farming
- Batch 8 stocked end August and batch 9 end October bringing farm to steady-state number of individuals of 1.5-1.6 million.
- Available liquidity of
NOK 705 million per30 September 2023 including committed available undrawn credit facilities. - Q4 harvest expectation 1,000 – 1,200 tonnes (HOG).
Results presentation:
CEO
Participants may also follow the presentation and submit questions through a live webcast available on www.salmonevolution.no, or with the following link: https://events.webcast.no/salmon-evolution/OEpmPDaoyhi5siPjdg0b/YpjX2kRpv5cFisuvNmU6
The presentation and Q&A will be held in English.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
For further information, please contact:
[email protected]
+47 91 19 13 27
Trond Vadset Veibust, CFO
[email protected]
+47 48 09 05 95
The following files are available for download:
https://mb.cision.com/Public/19899/3876058/afe4651af3d8c6a3.pdf | SALME Q3 2023 Report |
https://mb.cision.com/Public/19899/3876058/814e1ee29112fc03.pdf | SALME Q3 2023 Presentation |
View original content:https://www.prnewswire.com/news-releases/salmon-evolution-asa-results-for-q3-2023-301988609.html
SOURCE Salmon Evolution
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AEON Launches Agentic Checkout V2, Bringing AI-Powered Travel Booking to Travala
- Abbott presents new ESMO data showing 30-percent absolute improvement in sensitivity with the whole-genome sequencing Oncodetect® test in colorectal cancer
- Monero Price Prediction: XMR Jumps Nearly 10% Toward $650 as Remittix’s $33M Raise Sets Up Its November Catalyst
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share